InMed Pharmaceuticals Inc.
INM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728328
In the last 90 days, InMed Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $4.18M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in InMed Pharmaceuticals Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- +1 vs. Q2 2024
- Shares held
- 1.14M
- +701.7K (+159.4%) vs. Q2 2024
- Total value
- $266.0K
- +$149.4K (+128.1%) vs. Q2 2024
- New holders
- 6
- 2 more added
- Sold out
- 5
- 3 more reduced
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $4.18M |
| Q1 2026 | 9 | $206.0K |
| Q4 2025 | 7 | $240.7K |
| Q3 2025 | 9 | $665.2K |
| Q2 2025 | 7 | $28.5K |
| Q1 2025 | 5 | $13.3K |
| Q4 2024 | 5 | $226.7K |
| Q3 2024 | 15 | $266.0K |
| Q2 2024 | 14 | $116.6K |
| Q1 2024 | 18 | $249.2K |
| Q4 2023 | 17 | $334.4K |
| Q3 2023 | 10 | $18.6K |
| Q2 2023 | 10 | $14.5K |
| Q1 2023 | 15 | $109.4K |
| Q4 2022 | 14 | $234.4K |
| Q3 2022 | 15 | $876.9K |
| Q2 2022 | 18 | $514.5K |
| Q1 2022 | 19 | $341.9K |
| Q4 2021 | 18 | $536.4K |
| Q3 2021 | 19 | $979.9K |
| Q2 2021 | 20 | $2.99M |
| Q1 2021 | 22 | $1.55M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding InMed Pharmaceuticals Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AdvisorShares Investments LLC | 733,296 | $171.7K | 0.03% | +733,296 | New |
| UBS Group AG | 212,039 | $50.3K | 0.00% | +212,039 | New |
| Citadel Advisors LLC | 56,666 | $13.3K | 0.00% | +44,569+368.4% | Added |
| Renaissance Technologies LLC | 50,296 | $11.9K | 0.00% | +50,296 | New |
| HRT Financial LP | 38,369 | $8.00K | 0.00% | +22,373+139.9% | Added |
| Virtu Financial LLC | 28,415 | $7.00K | 0.00% | −58,269−67.2% | Reduced |
| Baader Bank INC | 22,611 | $3.84K | 0.00% | +22,611 | New |
| Bank of America Corp | 100 | $24 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 27 | $5 | 0.00% | −5−15.6% | Reduced |
| AllSquare Wealth Management LLC | 21 | $5 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 19 | $5 | 0.00% | +19 | New |
| Global Retirement Partners, LLC | 6 | $1 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 24 | $0 | 0.00% | −1−4.0% | Reduced |
| Gables Capital Management Inc. | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Banque Cantonale Vaudoise | 125 | $0 | 0.00% | +125 | New |
| Sabby Management, LLC | 0 | $0 | 0.00% | −307,236−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −17,819−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| TD Waterhouse Canada Inc. | 0 | $0 | 0.00% | −85−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −2−100.0% | Sold out |